Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
about
A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines.Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice.Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.Enhanced reactive oxygen species overexpression by CuO nanoparticles in poorly differentiated hepatocellular carcinoma cells.(+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration.Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.The inhibitor of Ca(2+)-dependent K+ channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB.Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response.NO and COX2: Dual targeting for aggressive cancers.Tumor-related gene changes in immunosuppressive Syrian hamster cholangiocarcinoma.Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
P2860
Q33898852-7BDBFD1F-93A2-4396-A724-29603C7FA1A8Q37127122-1420ED89-D629-4D1F-B8BF-5770A4F7DF69Q37476446-2693A24A-D2BB-4D36-A70A-E4DA0BD62A3CQ37735173-30828F17-F03D-4E3D-9D43-1D45311B55C9Q38698770-91E433CE-C0BD-45EF-8AC1-0753B0A812C1Q38927376-905F5D28-1722-4CA6-AD6F-DE77390E6F80Q39448845-525B70C6-0AEF-437A-95D2-806B3249AF58Q39561085-F556144B-9636-4E2C-B8C3-EDC490CB2226Q41918404-3C1DD348-CA19-427B-BA7F-26F1DC02B1DFQ42616887-D5CD7A43-6BA8-41AA-9EB8-6B5673BCA04EQ44017901-30552D86-EAC9-407B-BDFA-E36DE06D36D6Q45227714-134D5832-FD30-4070-B401-B374EB63DCAEQ48122606-5E413FE3-BC9D-48DA-BE4D-7A5EAC89FD47Q51018355-1937EB6F-EF63-4243-BE4C-90E4735B890CQ53186782-F5A17EBD-F144-4AB2-A978-96ED94086587
P2860
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Aberrant iNOS signaling is und ...... gnostic for the human disease.
@en
Aberrant iNOS signaling is und ...... gnostic for the human disease.
@nl
type
label
Aberrant iNOS signaling is und ...... gnostic for the human disease.
@en
Aberrant iNOS signaling is und ...... gnostic for the human disease.
@nl
prefLabel
Aberrant iNOS signaling is und ...... gnostic for the human disease.
@en
Aberrant iNOS signaling is und ...... gnostic for the human disease.
@nl
P2093
P2860
P356
P1433
P1476
Aberrant iNOS signaling is und ...... ognostic for the human disease
@en
P2093
Diego F Calvisi
Federico Pinna
Francesco Feo
Maddalena Frau
Maria A Seddaiu
Maria L Tomasi
Maria M Simile
Maria R De Miglio
Maria R Muroni
Rosa M Pascale
P2860
P304
P356
10.1093/CARCIN/BGN155
P407
P50
P577
2008-06-25T00:00:00Z